Monogram Technologies Inc
MGRM5.408USD
+0.018+0.33%
Trading geöffnet （ET）Kurse um 15 Minuten verzögert
191.15MMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über Monogram Technologies Inc Unternehmen
Monogram Technologies Inc., formerly Monogram Orthopaedics Inc., is an artificial intelligence (AI)-driven robotics company focused on improving human health, with an initial focus on orthopedic surgery. The Company is developing a product solution architecture to enable patient-optimized orthopedic implants at scale by combining three-dimensional (3D) printing, advanced machine vision, AI and robotics. Its mBos precision robotic surgical system is designed to autonomously execute optimized paths for high-precision insertion of its mPress press-fit implants. The Company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures. The Company is also exploring other clinical and commercial applications for the mBos with mVision navigation.
Unternehmensinformationen
BörsenkürzelMGRM
Name des UnternehmensMonogram Technologies Inc
IPO-datumMay 18, 2023
CEOMr. Benjamin Sexson
Anzahl der mitarbeiter27
WertpapierartOrdinary Share
GeschäftsjahresendeMay 18
Addresse53 Bridge Street Unit 507
StadtBROOKLYN
BörseNASDAQ Capital Market Consolidated
LandUnited States of America
Postleitzahl11201
Telefon17185763205
Websitehttps://www.monogramtechnologies.com/
BörsenkürzelMGRM
IPO-datumMay 18, 2023
CEOMr. Benjamin Sexson
Führungskräfte
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Benjamin Sexson
Mr. Benjamin Sexson
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
4.01M
--
Mr. Douglas Unis, M.D.
Mr. Douglas Unis, M.D.
Director and founder
Director and founder
3.48M
-1.62%
Mr. Noel Knape, CPA
Mr. Noel Knape, CPA
Chief Financial Officer
Chief Financial Officer
288.79K
+0.11%
Mr. Kamran Shamaei, Ph.D.
Mr. Kamran Shamaei, Ph.D.
Chief Technology Officer
Chief Technology Officer
2.93K
--
Mr. Richard L. (Rick) Van Kirk, Jr.
Mr. Richard L. (Rick) Van Kirk, Jr.
Independent Director
Independent Director
--
--
Mr. Chris Tyson
Mr. Chris Tyson
Executive Vice President
Executive Vice President
--
--
Ms. Colleen M. Gray
Ms. Colleen M. Gray
Independent Director
Independent Director
--
--
Mr. Paul Riss, CPA
Mr. Paul Riss, CPA
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Benjamin Sexson
Mr. Benjamin Sexson
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
4.01M
--
Mr. Douglas Unis, M.D.
Mr. Douglas Unis, M.D.
Director and founder
Director and founder
3.48M
-1.62%
Mr. Noel Knape, CPA
Mr. Noel Knape, CPA
Chief Financial Officer
Chief Financial Officer
288.79K
+0.11%
Mr. Kamran Shamaei, Ph.D.
Mr. Kamran Shamaei, Ph.D.
Chief Technology Officer
Chief Technology Officer
2.93K
--
Mr. Richard L. (Rick) Van Kirk, Jr.
Mr. Richard L. (Rick) Van Kirk, Jr.
Independent Director
Independent Director
--
--
Mr. Chris Tyson
Mr. Chris Tyson
Executive Vice President
Executive Vice President
--
--
Umsatzaufteilung
FY2024
Keine Daten
Nach RegionUSD
Name
Umsatz
Anteil
United States
0.00
0.00%
Nach Geschäftsbereich
Nach Region
Keine Daten
Aktionärsstatistik
Aktualisiert: Thu, Jul 17
Aktualisiert: Thu, Jul 17
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Zimmer Biomet Holdings, Inc.
26.98%
Sexson (Benjamin)
11.08%
Unis (Douglas)
9.61%
Icahn School of Medicine at Mount Sinai
6.53%
Pro-Dex Inc
5.06%
Other
40.75%
Aktionäre
Aktionäre
Anteil
Zimmer Biomet Holdings, Inc.
26.98%
Sexson (Benjamin)
11.08%
Unis (Douglas)
9.61%
Icahn School of Medicine at Mount Sinai
6.53%
Pro-Dex Inc
5.06%
Other
40.75%
Aktionärstypen
Aktionäre
Anteil
Holding Company
26.98%
Individual Investor
21.50%
Corporation
11.58%
Investment Advisor
3.84%
Investment Advisor/Hedge Fund
1.04%
Research Firm
0.16%
Hedge Fund
0.05%
Other
34.86%
Institutionelle Beteiligung
Aktualisiert: Tue, Jul 1
Aktualisiert: Tue, Jul 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q2
72
13.80M
38.16%
+158.05K
2025Q1
70
13.80M
38.67%
+170.39K
2024Q4
67
13.51M
39.38%
+322.57K
2024Q3
55
13.06M
41.28%
+264.50K
2024Q2
44
12.27M
38.78%
-449.19K
2024Q1
41
12.14M
38.38%
-162.63K
2023Q4
32
12.30M
41.64%
+1.57M
2023Q3
22
10.73M
36.66%
+319.53K
2023Q2
15
7.55M
25.82%
+7.55M
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Sexson (Benjamin)
4.01M
11.23%
--
--
Mar 05, 2025
Unis (Douglas)
3.48M
9.74%
-57.12K
-1.62%
Mar 05, 2025
Icahn School of Medicine at Mount Sinai
2.36M
6.61%
--
--
Mar 05, 2025
Pro-Dex Inc
1.83M
5.12%
--
--
Mar 05, 2025
The Vanguard Group, Inc.
896.70K
2.51%
+241.15K
+36.79%
Mar 31, 2025
Knape (Noel)
288.79K
0.81%
+329.00
+0.11%
Mar 05, 2025
Geode Capital Management, L.L.C.
243.41K
0.68%
+17.03K
+7.52%
Mar 31, 2025
Buckingham Strategic Partners, LLC
213.68K
0.6%
+12.33K
+6.12%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
93.73K
0.26%
-846.00
-0.89%
Mar 31, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Sat, Aug 2
Aktualisiert: Sat, Aug 2
Name
Anteil
iShares Micro-Cap ETF
0.02%
iShares Micro-Cap ETF
Anteil0.02%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten
